<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="article-commentary" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">55960</article-id><article-id pub-id-type="doi">10.7554/eLife.55960</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Translation</subject></subj-group></article-categories><title-group><article-title>Finding sense in the context</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-178194"><name><surname>Keeling</surname><given-names>Kim M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0471-5858</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Kim M Keeling</bold> is in the Department of Biochemistry and Molecular Genetics and the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, United States</p></bio></contrib><contrib contrib-type="author" corresp="yes" id="author-6406"><name><surname>Bedwell</surname><given-names>David M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6605-818X</contrib-id><email>dbedwell@uab.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>David M Bedwell</bold> is in the Department of Biochemistry and Molecular Genetics and the Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, United States</p></bio></contrib><aff id="aff1"><label>1</label><institution>Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham</institution><addr-line><named-content content-type="city">Birmingham</named-content></addr-line><country>United States</country></aff></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>23</day><month>03</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e55960</elocation-id><history><date date-type="received" iso-8601-date="2020-03-17"><day>17</day><month>03</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-03-17"><day>17</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Keeling and Bedwell</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Keeling and Bedwell</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-55960-v1.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="commentary-article" xlink:href="10.7554/eLife.52611"/><abstract><p>Ribosomal profiling has shed new light on how ribosomes can ignore stop codons in messenger RNA.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>aminoglycoside</kwd><kwd>ribosome</kwd><kwd>readthrough</kwd><kwd>ribosome profiling</kwd><kwd>translation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Ribosomal profiling has shed new light on how ribosomes can ignore stop codons in messenger RNA.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Wangen JR, Green R. 2020. Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides. <italic>eLife</italic> <bold>9</bold>:e52611. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.52611">10.7554/eLife.52611</ext-link></p></boxed-text><p>When a ribosome is translating a molecule of messenger RNA (mRNA) to produce a protein, it stops when it encounters a triplet of nucleotides called a termination codon. Ribosomes recognize three different termination codons – UAG, UAA and UGA – but a genetic event called a nonsense mutation can change a codon that normally codes for an amino acid – such as UAU, which codes for tyrosine – into a codon that stops translation prematurely. This results in the production of a truncated protein that does not work properly. Indeed, nonsense mutations cause a wide range of genetic conditions in millions of people worldwide, representing as much as 11% of all disease-associated gene lesions (<xref ref-type="bibr" rid="bib7">Mort et al., 2008</xref>).</p><p>One way to treat the conditions caused by nonsense mutations would be to target premature termination events (<xref ref-type="bibr" rid="bib4">Lee and Dougherty, 2012</xref>; <xref ref-type="bibr" rid="bib3">Keeling et al., 2014</xref>; <xref ref-type="bibr" rid="bib2">Dabrowski et al., 2018</xref>). For example, small molecules such as aminoglycoside antibiotics can help ribosomes to ignore premature termination codons and produce some full-length working proteins, an event called ‘readthrough’. However, aminoglycosides may also help ribosomes to readthrough normal termination codons: this can produce longer-than-normal proteins that are harmful to cells.</p><p>Now, in eLife, Jamie Wangen and Rachel Green of Johns Hopkins University School of Medicine report new insights into the way that aminoglycosides suppress termination (<xref ref-type="bibr" rid="bib10">Wangen and Green, 2020</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>). To do so, they harnessed and adapted a method known as ribosomal profiling, which reveals all the mRNAs that are being translated at a given time in a cell. In particular, the technique can highlight where ribosomes start and stop translation (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Using ribosomal profiling to assess the efficiency of translation termination.</title><p>At any given time, a number of ribosomes (grey ovals) will be attached to messenger RNA molecules at different positions. Ribosomal profiling is a technique that can help to locate ribosomes on the mRNA they are translating at the scale of the genome. First, each ribosome (and the region of mRNA it is attached to) is isolated. These segments are then treated with nucleases, releasing the RNA sequences the ribosomes were bound to. These are then purified and sequenced. During efficient termination (left), most of the ribosomes are between the start codon (green) and the stop codon (red), with the majority accumulating at the stop codon (graph on the bottom left), where translation stops. During inefficient termination (right), for example under the influence of small molecules such as G418, ribosomes can ‘readthrough’ the termination codon and carry on translating downstream (graph on the bottom right).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55960-fig1-v1.tif"/></fig><p>First, Wangen and Green used ribosomal profiling to examine translation in human cells treated with the aminoglycoside G418. Cells that were exposed to G418 had fewer ribosomes attached to normal termination codons; more ribosomes, however, were bound to regions of mRNA downstream of these termination codons, indicating that readthrough had occurred (thus allowing ribosomes to continue to translate past the normal stop points). Together, these findings indicate that G418 helps ribosomes to bypass normal termination codons; other results also suggest that the drug broadly interferes with other steps of the translation process.</p><p>Second, ribosomal profiling was used to examine how the mRNA sequence around a termination codon influences readthrough: this approach confirmed and built upon results from a number of previous studies (<xref ref-type="bibr" rid="bib6">Martin, 1994</xref>; <xref ref-type="bibr" rid="bib9">Phillips-Jones et al., 1995</xref>; <xref ref-type="bibr" rid="bib5">Manuvakhova et al., 2000</xref>; <xref ref-type="bibr" rid="bib1">Cassan and Rousset, 2001</xref>; <xref ref-type="bibr" rid="bib8">Namy et al., 2001</xref>). Whether the termination codon was UAG, UAA or UGA, the identity of the two nucleotides directly downstream of these sequences had the greatest impact on readthrough. In addition, if neighboring sequences were rich in adenine and uridine, readthrough became more frequent.</p><p>Third, in cells treated with G418, readthrough events happened less often for normal termination codons than they did for other, downstream termination codons (which are not normally read by ribosomes). This indicates that normal termination codons have evolved safeguards to protect themselves from readthrough. It also suggests it may be possible to target premature termination codons – which may be more vulnerable since they have not been through a similar selection process – without disrupting accurate termination events.</p><p>Fourth, Wangen and Green explored the biological consequences of G418 inducing readthrough of normal termination codons. The majority of mRNAs were only modestly affected, but certain genes were more sensitive to the translation events induced by the drug – namely, the histone, selenoprotein, and S-adenosylmethionine decarboxylase genes.</p><p>Multiple genetic and biochemical studies have investigated the mechanisms of nonsense suppression, but only for a few transcripts at a time. The work by Wangen and Green, on the other hand, highlights how ribosomal profiling can confirm these findings at a genomic level. This confirmation is important when considering how to suppress premature termination codons for therapeutic purposes. By adapting ribosomal profiling to explore translation termination, Wangen and Green have created an important tool to investigate nonsense suppression in normal circumstances and under the influence of aminoglycosides. The method could also be used to examine how other readthrough agents act on premature and normal termination codons, as well as on global gene expression. This work could potentially help to identify new, safe and effective molecules that could be developed for clinical use.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassan</surname> <given-names>M</given-names></name><name><surname>Rousset</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals</article-title><source>BMC Molecular Biology</source><volume>2</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2199-2-3</pub-id><pub-id pub-id-type="pmid">11242562</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabrowski</surname> <given-names>M</given-names></name><name><surname>Bukowy-Bieryllo</surname> <given-names>Z</given-names></name><name><surname>Zietkiewicz</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons</article-title><source>Molecular Medicine</source><volume>24</volume><elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.1186/s10020-018-0024-7</pub-id><pub-id pub-id-type="pmid">30134808</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keeling</surname> <given-names>KM</given-names></name><name><surname>Xue</surname> <given-names>X</given-names></name><name><surname>Gunn</surname> <given-names>G</given-names></name><name><surname>Bedwell</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Therapeutics based on stop codon readthrough</article-title><source>Annual Review of Genomics and Human Genetics</source><volume>15</volume><fpage>371</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1146/annurev-genom-091212-153527</pub-id><pub-id pub-id-type="pmid">24773318</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>HL</given-names></name><name><surname>Dougherty</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Pharmaceutical therapies to recode nonsense mutations in inherited diseases</article-title><source>Pharmacology &amp; Therapeutics</source><volume>136</volume><fpage>227</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2012.07.007</pub-id><pub-id pub-id-type="pmid">22820013</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manuvakhova</surname> <given-names>M</given-names></name><name><surname>Keeling</surname> <given-names>K</given-names></name><name><surname>Bedwell</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system</article-title><source>RNA</source><volume>6</volume><fpage>1044</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1017/S1355838200000716</pub-id><pub-id pub-id-type="pmid">10917599</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>On the relationship between preferred termination codon contexts and nonsense suppression in human cells</article-title><source>Nucleic Acids Research</source><volume>22</volume><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1093/nar/22.1.15</pub-id><pub-id pub-id-type="pmid">8127650</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mort</surname> <given-names>M</given-names></name><name><surname>Ivanov</surname> <given-names>D</given-names></name><name><surname>Cooper</surname> <given-names>DN</given-names></name><name><surname>Chuzhanova</surname> <given-names>NA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A meta-analysis of nonsense mutations causing human genetic disease</article-title><source>Human Mutation</source><volume>29</volume><fpage>1037</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1002/humu.20763</pub-id><pub-id pub-id-type="pmid">18454449</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namy</surname> <given-names>O</given-names></name><name><surname>Hatin</surname> <given-names>I</given-names></name><name><surname>Rousset</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Impact of the six nucleotides downstream of the stop codon on translation termination</article-title><source>EMBO Reports</source><volume>2</volume><fpage>787</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1093/embo-reports/kve176</pub-id><pub-id pub-id-type="pmid">11520858</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips-Jones</surname> <given-names>MK</given-names></name><name><surname>Hill</surname> <given-names>LS</given-names></name><name><surname>Atkinson</surname> <given-names>J</given-names></name><name><surname>Martin</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Context effects on misreading and suppression at UAG codons in human cells</article-title><source>Molecular and Cellular Biology</source><volume>15</volume><fpage>6593</fpage><lpage>6600</lpage><pub-id pub-id-type="doi">10.1128/MCB.15.12.6593</pub-id><pub-id pub-id-type="pmid">8524224</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wangen</surname> <given-names>JR</given-names></name><name><surname>Green</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides</article-title><source>eLife</source><volume>9</volume><elocation-id>e52611</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.52611</pub-id><pub-id pub-id-type="pmid">31971508</pub-id></element-citation></ref></ref-list></back></article>